Increased Sulfiredoxin Expression in Gastric Cancer Cells May Be a Molecular Target of the Anticancer Component Diallyl Trisulfide

Figure 1

Sulfiredoxin (Srx) protein expression in gastric cancer tissues and normal gastric tissues. Clinical tissue specimens were collected from surgical resection for gastric adenocarcinoma. Immunohistochemistry was performed using a home-made antibody. The sections were counterstained with hematoxylin to indicate the nuclei. The association between Srx expression and tumor incidence was determined using the chi-square test.